# Albumin Infusion in Inpatients With Decompensated Cirrhosis

> **NCT05719051** · — · UNKNOWN · sponsor: **Ruijin Hospital** · enrollment: 564 (estimated)

## Conditions studied

- Decompensated Cirrhosis
- Acute-On-Chronic Liver Failure

## Interventions

- **DRUG:** Albumin infusion

## Key facts

- **NCT ID:** NCT05719051
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 564 (ESTIMATED)
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05719051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05719051, "Albumin Infusion in Inpatients With Decompensated Cirrhosis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05719051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*